参天製薬株式会社
1925-01-01
TYO
Japan
研究・開発
生産・信頼性保証
パートナリング
医薬品の研究開発
医薬品の製造
医薬品の販売
医療機器の研究開発
医療機器の製造
医療機器の販売
〒530-8552 大阪市北区大深町4番20号 グランフロント大阪 タワーA (受付 25F)
伊藤 毅
8,824,000,000  (88 100 million)
1,756 people
4,000 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
FTSE International Limited
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
FTSE Russell
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
ISS ESG
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Portugal
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
SANTEN PHARMA MALAYSIA SDN. BHD.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
SOMPO Asset Management
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Santen Portugal
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Santen製薬(中国)有限公司
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Sweden (FI Oy)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
イタリア赤十字社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
ネクストファーマ
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
中国紅十字会
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
参天アイケア株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
参天投資(中国)有限公司
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
台南市政府
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
蘇州工場(中国)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Great Place to Work®
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Supplier
一般財団法人インターナショナル・ブ ラインドフットボール・ファウンデーション(IBF Foundation)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Alliance
特定非営利活動法人日本ブラインドサッカー協会(JBFA)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Alliance
GOVERNMENT OF NORWAY
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
NORTHERN TRUST CO. (AVFC) RE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE EQUITY TRUST
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
NORTHERN TRUST CO. (AVFC) RE U.S. TAX EXEMPTED PENSION FUNDS
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder

32 entries
DateDescription
1890 1890年,田口參天堂於大阪北濱開業,為參天製藥的起點。當時的主力商品為感冒藥「ヘブリン丸」。
1890 1890年に、田口謙吉が田口参天堂を開業したのが当社の始まりです。当時の主力製品は、「ヘブリン丸」というかぜ薬でした。
1890 創業,推出感冒藥「ヘブリン丸」 : 1890年,田口參天堂於大阪北濱開業,為參天製藥的起點。當時的主力商品為感冒藥「ヘブリン丸」
1890 1890年に大阪で創業し、田口謙吉が田口参天堂を開業した
1899 1899年推出「大學眼藥」,利用宣傳標語「時代進步的產物,卓越超群的眼藥」及大學教授形象商標,迅速遍及日本全國。
1899 1899年に「大学目薬」を発売し、その人気は日本中に広まりました。
1899 推出「大學眼藥」 : 明治初期,許多來日的外國醫師對於日本人罹患眼疾的比例之高感到十分驚訝,由此可知當時日本對於眼藥的需求非常大。正當此時推出的「大學眼藥」,利用充滿自信的宣傳標語「時代進步的產物,卓越超群的眼藥」,和富有權威感的大學教授形象商標展開行銷,迅速遍及日本全國。
1899 1899年にSantenで初となる眼科製品として「大学目薬」を発売しました
1914 1914年成立合資公司參天堂,三田忠幸以共同經營者的身分正式參與經營。
1914 成立合資公司參天堂 : 1914年成立合資公司參天堂,三田忠幸以共同經營者的身分正式參與經營。
1925 1925年設立參天堂株式會社,由三田忠幸擔任第一代社長。
1925 設立參天堂株式會社 : 1925年設立參天堂株式會社,由三田忠幸擔任第一代社長,建立了參天製藥的發展基礎。
1935 1935年在大阪市東淀川區設立淀川工廠,為日後總公司所在地。
1935 設立淀川工廠 : 1935年設立淀川工廠,在大阪市東淀川區設立淀川工廠,為日後總公司所在地。
1944 1944年、第二次世界大戰空襲後、総会社、高麗橋工廠、中崎町工廠及櫻川工廠全數燒毀。総会社遷移至淀川工廠。
1944 總公司遷移至淀川工廠 : 1944年總公司遷移至淀川工廠。
1945 1945年改名為參天堂製藥株式會社。
1945 改名參天堂製藥株式會社 : 1945年改名參天堂製藥株式會社。
1952 1952年(昭和27年)以眼藥為中心,重新整頓事業內容。
1952 以眼藥為中心,重新整頓事業內容 : 1952年以眼藥為中心,重新整頓事業內容。
1958 進入醫療用藥品市場 : 1958年進入醫療用藥品市場,正式改名為參天製藥株式會社。
1962 發售日本首支使用塑膠容器之眼藥水「Super Sante」 : 1962年發售日本首支使用塑膠容器之眼藥水「Super Sante」。
1963 發售自行研發的產品「Thiola」 : 1963年發售自行研發的產品「Thiola」。
1965 發售「Sante De U」眼藥水 : 1965年發售「Sante De U」眼藥水。
1970 發售「Ecolicin」點眼液、發售「Kari Uni」點眼液、奈良研發中心及滋賀工廠完工、發售「Cravit」點眼液、引進全新型態容器「Dimple Bottle」、發售「Sante De U Plus E α」眼藥水、「Sante 40」眼藥水、「Sante 40V」眼藥水、併購法國公司Novagali Pharma S.A. (連結子公司)、發售「Elyea」玻璃體內注射液、發售「Sante Medical Guard」眼藥水、「Sante 40 系列」眼藥水、發售「TAPROS MINI」點眼液、發售「Alesion」點眼液、發售人工水晶體「Eternity Natural Uni」、發售「Sante Beauteye」眼藥水、「Sante PC」眼藥水、「Sante 快滴40」眼藥水、「Sante ALn」眼藥水。
1990 1990年に長期ビジョンを発表。目と健康をテーマとして最高の製品とサービスで社会に貢献することを掲げ、新たな成長ステージへと突入しました。
1990 1990年に製品ラインアップの拡充による日本での事業成長や滋賀工場竣工などに加え、欧州市場への参入を果たしました。
1990 1990年に欧州市場への参入を果たし、世界の患者さんへの貢献に向けた積極的な事業展開に注力しました。
1990 1990年に中国で自社販売や蘇州工場竣工、韓国で拠点設立など、アジアでの事業基盤の構築に取り組みました。
1990 1990年を機に、創業100周年を迎え、長期ビジョンを発表し、製品ラインアップの拡充や滋賀工場竣工、欧州市場への参入を果たしました
2014 2014年(平成26年)承接美國默克藥廠之眼藥水產品,於瑞士、義大利、英國、西班牙、泰國、馬來西亞、菲律賓設立子公司,發售「TAPCOM」點眼液及「Soft Santear Hitomi Stretch」眼藥水。
2014 承接美國默克藥廠之眼藥水產品、於瑞士、義大利、英國、西班牙、泰國、馬來西亞、菲律賓設立子公司、發售「TAPCOM」點眼液、發售「Soft Santear Hitomi Stretch」眼藥水、併購美國公司InnFocus、發售「Sante Medical 12」眼藥水、「Sante Medical Guard EX」眼藥水、「Sante Medical Active」眼藥水、發售人工水晶體「Eternity Natural Unir」、發售「Sante Beauteye Contact」眼藥水。
+ Loaded when opened
5120001051819
Trade name参天製薬株式会社
Trade name (kana)サンテンセイヤク
Name in English
Corporation type301
Address〒530-0011 大阪府大阪市北区大深町4番20号
Postal code5300011
Prefecture code27
City code127
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date2015-10-05
Update date2020-01-17
Change date2020-01-15
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record1
Excluded from search0
Processing type12
Correction type0
Trade name image ID
Address image ID
Sequence number4199900
Source: National Tax Agency Corporate Number Publication Site, basic three items
5120001051819
Corporate number5120001051819
Trade name参天製薬株式会社
Trade name (kana)サンテンセイヤク
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address大阪府大阪市北区大深町4番20号
Postal code5300011
Prefecture大阪府
Prefecture code27
City or district大阪市北区
City code127
Street address大深町4番20号
Organisation type301
Processing type12
Correction type0
Status
Representative代表取締役社長兼CEO 伊藤 毅
Capital8806000000
Employees1802
Employees (male)1348
Employees (female)459
Business summary医薬品および医療機器の研究開発・製造・販売
Website URLhttps://www.santen.co.jp/ja/
Year founded
Business categoryE:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date2020-01-17
Key information5120001051819
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-21 17:56 (Model: ggml-org/gpt-oss-20b )
↑